141 related articles for article (PubMed ID: 26575390)
1. Computer-assisted designed "selenoxy-chinolin": a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation.
Wang Z; Wang Y; Li W; Liu Z; Luo Z; Sun Y; Wu R; Huang L; Li X
Dalton Trans; 2015 Dec; 44(48):20913-25. PubMed ID: 26575390
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease.
Luo Z; Liang L; Sheng J; Pang Y; Li J; Huang L; Li X
Bioorg Med Chem; 2014 Feb; 22(4):1355-61. PubMed ID: 24461494
[TBL] [Abstract][Full Text] [Related]
3. Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants.
Bhabak KP; Mugesh G
Acc Chem Res; 2010 Nov; 43(11):1408-19. PubMed ID: 20690615
[TBL] [Abstract][Full Text] [Related]
4. Unusual Cyclodextrin Derivatives as a New Avenue to Modulate Self- and Metal-Induced Aβ Aggregation.
Oliveri V; Bellia F; Pietropaolo A; Vecchio G
Chemistry; 2015 Sep; 21(40):14047-59. PubMed ID: 26298549
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[d][1,2]selenazol-3(2H)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant.
Wang B; Wang Z; Chen H; Lu CJ; Li X
Bioorg Med Chem; 2016 Oct; 24(19):4741-4749. PubMed ID: 27567080
[TBL] [Abstract][Full Text] [Related]
6. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
7. New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.
Mao F; Yan J; Li J; Jia X; Miao H; Sun Y; Huang L; Li X
Org Biomol Chem; 2014 Aug; 12(31):5936-44. PubMed ID: 24986600
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant activity of the anti-inflammatory compound ebselen: a reversible cyclization pathway via selenenic and seleninic acid intermediates.
Sarma BK; Mugesh G
Chemistry; 2008; 14(34):10603-14. PubMed ID: 18932179
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer's disease.
Wang Z; Wang Y; Li W; Mao F; Sun Y; Huang L; Li X
ACS Chem Neurosci; 2014 Oct; 5(10):952-62. PubMed ID: 25121395
[TBL] [Abstract][Full Text] [Related]
10. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions.
Sarma BK; Mugesh G
J Am Chem Soc; 2005 Aug; 127(32):11477-85. PubMed ID: 16089478
[TBL] [Abstract][Full Text] [Related]
11. Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.
Huang L; Lu C; Sun Y; Mao F; Luo Z; Su T; Jiang H; Shan W; Li X
J Med Chem; 2012 Oct; 55(19):8483-92. PubMed ID: 22978824
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and antioxidant activity of some ebselen analogues.
Bhabak KP; Mugesh G
Chemistry; 2007; 13(16):4594-601. PubMed ID: 17299817
[TBL] [Abstract][Full Text] [Related]
13. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
Fernández-Bachiller MI; Pérez C; González-Muñoz GC; Conde S; López MG; Villarroya M; García AG; Rodríguez-Franco MI
J Med Chem; 2010 Jul; 53(13):4927-37. PubMed ID: 20545360
[TBL] [Abstract][Full Text] [Related]
14. Novel 8-Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer's Disease.
Prati F; Bergamini C; Fato R; Soukup O; Korabecny J; Andrisano V; Bartolini M; Bolognesi ML
ChemMedChem; 2016 Jun; 11(12):1284-95. PubMed ID: 26880501
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease.
Lu C; Guo Y; Yan J; Luo Z; Luo HB; Yan M; Huang L; Li X
J Med Chem; 2013 Jul; 56(14):5843-59. PubMed ID: 23799643
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease.
Wang Z; Wang Y; Wang B; Li W; Huang L; Li X
J Med Chem; 2015 Nov; 58(21):8616-37. PubMed ID: 26473791
[TBL] [Abstract][Full Text] [Related]
18. Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer's disease.
Yang X; Cai P; Liu Q; Wu J; Yin Y; Wang X; Kong L
Bioorg Med Chem; 2018 Jul; 26(12):3191-3201. PubMed ID: 29729985
[TBL] [Abstract][Full Text] [Related]
19. New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.
Fu CL; Hsu LS; Liao YF; Hu MK
Arch Pharm (Weinheim); 2016 May; 349(5):327-41. PubMed ID: 27027880
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.
Luo Z; Sheng J; Sun Y; Lu C; Yan J; Liu A; Luo HB; Huang L; Li X
J Med Chem; 2013 Nov; 56(22):9089-99. PubMed ID: 24160297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
